113 related articles for article (PubMed ID: 23364535)
1. Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer.
Huang HF; Shu P; Murphy TF; Aisner S; Fitzhugh VA; Jordan ML
Mol Cancer Res; 2013 Apr; 11(4):427-39. PubMed ID: 23364535
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of adipocytes and prostaglandin E2 and its four receptor proteins EP1, EP2, EP3, and EP4 in the caprine cervix during spontaneous term labor.
Gu G; Gao Q; Yuan X; Huang L; Ge L
Biol Reprod; 2012 May; 86(5):159, 1-10. PubMed ID: 22402965
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.
Kashiwagi E; Shiota M; Yokomizo A; Itsumi M; Inokuchi J; Uchiumi T; Naito S
Endocr Relat Cancer; 2013 Jun; 20(3):431-41. PubMed ID: 23493387
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis.
Miyata Y; Ohba K; Matsuo T; Watanabe S; Hayashi T; Sakai H; Kanetake H
Urology; 2013 Jan; 81(1):136-42. PubMed ID: 23149328
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
9. Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy.
Arosh JA; Banu SK; Chapdelaine P; Fortier MA
Endocrinology; 2004 Jan; 145(1):407-17. PubMed ID: 14500566
[TBL] [Abstract][Full Text] [Related]
10. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
[TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney.
Morath R; Klein T; Seyberth HW; Nüsing RM
J Am Soc Nephrol; 1999 Sep; 10(9):1851-60. PubMed ID: 10477136
[TBL] [Abstract][Full Text] [Related]
12. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
Cipollone F; Fazia ML; Iezzi A; Cuccurullo C; De Cesare D; Ucchino S; Spigonardo F; Marchetti A; Buttitta F; Paloscia L; Mascellanti M; Cuccurullo F; Mezzetti A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1925-31. PubMed ID: 16020747
[TBL] [Abstract][Full Text] [Related]
13. Characterization of prostaglandin E2 receptors (EP2, EP4) in the horse oviduct.
Ball BA; Scoggin KE; Troedsson MH; Squires EL
Anim Reprod Sci; 2013 Nov; 142(1-2):35-41. PubMed ID: 24035156
[TBL] [Abstract][Full Text] [Related]
14. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
15. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J
Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486
[TBL] [Abstract][Full Text] [Related]
17. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
Ueta M; Matsuoka T; Sotozono C; Kinoshita S
Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
[TBL] [Abstract][Full Text] [Related]
19. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
[TBL] [Abstract][Full Text] [Related]
20. Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.
Hori R; Nakagawa T; Yamamoto N; Hamaguchi K; Ito J
BMC Neurosci; 2010 Mar; 11():35. PubMed ID: 20219142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
